Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis

B cells are key pathogenic drivers of chronic inflammation in rheumatoid arthritis (RA). There is limited understanding of the relationship between synovial B cell subsets and pathogenic antibody secreting cells (ASCs). This knowledge is crucial for the development of more targeted B-cell depleting...

Full description

Bibliographic Details
Main Authors: Elinor Wing, Catherine Sutherland, Katherine Miles, David Gray, Carl S. Goodyear, Thomas D. Otto, Stefan Breusch, Graeme Cowan, Mohini Gray
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1241474/full
_version_ 1797745123466936320
author Elinor Wing
Catherine Sutherland
Katherine Miles
David Gray
Carl S. Goodyear
Thomas D. Otto
Stefan Breusch
Graeme Cowan
Mohini Gray
author_facet Elinor Wing
Catherine Sutherland
Katherine Miles
David Gray
Carl S. Goodyear
Thomas D. Otto
Stefan Breusch
Graeme Cowan
Mohini Gray
author_sort Elinor Wing
collection DOAJ
description B cells are key pathogenic drivers of chronic inflammation in rheumatoid arthritis (RA). There is limited understanding of the relationship between synovial B cell subsets and pathogenic antibody secreting cells (ASCs). This knowledge is crucial for the development of more targeted B-cell depleting therapies. While CD11c+ double-negative 2 (DN2) B cells have been suggested as an ASC precursor in lupus, to date there is no proven link between the two subsets in RA. We have used both single-cell gene expression and BCR sequencing to study synovial B cells from patients with established RA, in addition to flow cytometry of circulating B cells. To better understand the differentiation patterns within the diseased tissue, a combination of RNA-based trajectory inference and clonal lineage analysis of BCR relationships were used. Both forms of analysis indicated that DN2 B cells serve as a major precursors to synovial ASCs. This study advances our understanding of B cells in RA and reveals the origin of pathogenic ASCs in the RA synovium. Given the significant role of DN2 B cells as a progenitor to pathogenic B cells in RA, it is important to conduct additional research to investigate the origins of DN2 B cells in RA and explore their potential as therapeutic targets in place of the less specific pan-B cells depletion therapies currently in use.
first_indexed 2024-03-12T15:18:58Z
format Article
id doaj.art-7be81bbfafaa40f7b7970a61171c4912
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-12T15:18:58Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-7be81bbfafaa40f7b7970a61171c49122023-08-11T06:07:08ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-08-011410.3389/fimmu.2023.12414741241474Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritisElinor Wing0Catherine Sutherland1Katherine Miles2David Gray3Carl S. Goodyear4Thomas D. Otto5Stefan Breusch6Graeme Cowan7Mohini Gray8Centre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United KingdomInstitute of Immunology and Infection Research, School of Biological Sciences, The King’s Buildings, The University of Edinburgh, Edinburgh, United KingdomCentre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United KingdomInstitute of Immunology and Infection Research, School of Biological Sciences, The King’s Buildings, The University of Edinburgh, Edinburgh, United KingdomInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United KingdomInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United KingdomOrthopaedic Unit, Royal Infirmary of Edinburgh, Edinburgh, United KingdomInstitute of Immunology and Infection Research, School of Biological Sciences, The King’s Buildings, The University of Edinburgh, Edinburgh, United KingdomCentre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United KingdomB cells are key pathogenic drivers of chronic inflammation in rheumatoid arthritis (RA). There is limited understanding of the relationship between synovial B cell subsets and pathogenic antibody secreting cells (ASCs). This knowledge is crucial for the development of more targeted B-cell depleting therapies. While CD11c+ double-negative 2 (DN2) B cells have been suggested as an ASC precursor in lupus, to date there is no proven link between the two subsets in RA. We have used both single-cell gene expression and BCR sequencing to study synovial B cells from patients with established RA, in addition to flow cytometry of circulating B cells. To better understand the differentiation patterns within the diseased tissue, a combination of RNA-based trajectory inference and clonal lineage analysis of BCR relationships were used. Both forms of analysis indicated that DN2 B cells serve as a major precursors to synovial ASCs. This study advances our understanding of B cells in RA and reveals the origin of pathogenic ASCs in the RA synovium. Given the significant role of DN2 B cells as a progenitor to pathogenic B cells in RA, it is important to conduct additional research to investigate the origins of DN2 B cells in RA and explore their potential as therapeutic targets in place of the less specific pan-B cells depletion therapies currently in use.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1241474/fullrheumatoid arthritisdouble-negative-2 (DN2) B cellsantibody secreting cellssynoviumsingle-cell sequencing
spellingShingle Elinor Wing
Catherine Sutherland
Katherine Miles
David Gray
Carl S. Goodyear
Thomas D. Otto
Stefan Breusch
Graeme Cowan
Mohini Gray
Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis
Frontiers in Immunology
rheumatoid arthritis
double-negative-2 (DN2) B cells
antibody secreting cells
synovium
single-cell sequencing
title Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis
title_full Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis
title_fullStr Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis
title_full_unstemmed Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis
title_short Double-negative-2 B cells are the major synovial plasma cell precursor in rheumatoid arthritis
title_sort double negative 2 b cells are the major synovial plasma cell precursor in rheumatoid arthritis
topic rheumatoid arthritis
double-negative-2 (DN2) B cells
antibody secreting cells
synovium
single-cell sequencing
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1241474/full
work_keys_str_mv AT elinorwing doublenegative2bcellsarethemajorsynovialplasmacellprecursorinrheumatoidarthritis
AT catherinesutherland doublenegative2bcellsarethemajorsynovialplasmacellprecursorinrheumatoidarthritis
AT katherinemiles doublenegative2bcellsarethemajorsynovialplasmacellprecursorinrheumatoidarthritis
AT davidgray doublenegative2bcellsarethemajorsynovialplasmacellprecursorinrheumatoidarthritis
AT carlsgoodyear doublenegative2bcellsarethemajorsynovialplasmacellprecursorinrheumatoidarthritis
AT thomasdotto doublenegative2bcellsarethemajorsynovialplasmacellprecursorinrheumatoidarthritis
AT stefanbreusch doublenegative2bcellsarethemajorsynovialplasmacellprecursorinrheumatoidarthritis
AT graemecowan doublenegative2bcellsarethemajorsynovialplasmacellprecursorinrheumatoidarthritis
AT mohinigray doublenegative2bcellsarethemajorsynovialplasmacellprecursorinrheumatoidarthritis